J. B. Chemicals & Pharmaceuticals 2026 Forecast

J. B. Chemicals & Ph...

BSE:506943

Rp 2.082,50

Rp0,00 (0,00%)

2.082,50 Rp

Rp0,00 (0,00%)

End-of-day quote: 03/27/2026

J. B. Chemicals & Pharmaceuticals Stock Value

Analysts currently rate BSE:506943 as Outperform.

Outperform

J. B. Chemicals & Pharmaceuticals Company Info

EPS Growth 5Y

18,76%

Market Cap

Rp334,36 B

Long-Term Debt

Rp0,24 B

Annual earnings

05/14/2026 (E)

Dividend

Rp19,78

Dividend Yield

0,95%

Founded

1976

Industry

Health Care

Country

India

Website

J. B. Chemicals & Pharmaceuticals

ISIN Number

INE572A01036

Website

http://www.jbpharma.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp2.250,00

8.04%

Last Update: 03/28/2026

Analysts: 9

Highest Price Target Rp2.320,00

Average Price Target Rp2.250,00

Lowest Price Target Rp1.900,00

In the last five quarters, J. B. Chemicals & Pharmaceuticals’s Price Target has risen from Rp2.047,93 to Rp2.143,77 - a 4,68% increase. Seven analysts predict that J. B. Chemicals & Pharmaceuticals’s share price will increase in the coming year, reaching Rp2.250,00. This would represent an increase of 8,04%.

Top growth stocks in the health care sector (5Y.)

What does J. B. Chemicals & Pharmaceuticals do?

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. Business Segments The company operates through the Prescription Segment, OTC segment, Specialty and Biologics segment, and Contract Manufacturing Services. Prescription The Prescription segment of the company focuses on developing a wide array of medications aimed at treating chronic diseases and acute condi...

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Business Segments

The company operates through the Prescription Segment, OTC segment, Specialty and Biologics segment, and Contract Manufacturing Services.

Prescription

The Prescription segment of the company focuses on developing a wide array of medications aimed at treating chronic diseases and acute conditions. This includes innovative treatments for cardiovascular diseases, gastrointestinal disorders, and various infections. Additionally, the company invests heavily in research and development to ensure that its products meet the specific clinical needs of patients. By continuously enhancing its drug formulation capabilities, the company strives to deliver high-quality medications that are both effective and safe for patient use.

OTC

In the OTC (over the counter) segment, the company provides easily accessible medications that empower consumers to manage common health issues independently. This segment includes products designed for pain relief, cough and cold remedies, and digestive aids. The company markets these products through various channels to maximize consumer reach, ensuring that individuals can readily find solutions for minor ailments without the need for a prescription. This segment is crucial for enhancing brand visibility and consumer engagement.

Specialty and Biologics

The specialty and biologics segment showcases the company's commitment to innovation by developing advanced therapeutic products, often utilizing cutting-edge technologies. This segment focuses on creating specialized formulations that cater to complex medical conditions, thus improving patient outcomes. The company’s significant investments in research and development within this segment enable it to expand its therapeutic areas and address unmet medical needs effectively.

Contract Manufacturing Services

The company also offers contract manufacturing services, allowing other companies to leverage its manufacturing capabilities. This segment is essential for optimizing operational efficiencies and expanding the company’s market presence. By collaborating with other pharmaceutical firms, the company can enhance its production capacity and drive innovation in product development.

Business Strategy

The company embraces a multi-faceted business strategy aimed at solidifying its position as a leader in the pharmaceutical industry. Central to this strategy is a strong emphasis on innovation, diversification, and market expansion. Continuous investment in research and development allows the company to enhance its drug formulation capabilities, driving the development of new and improved products that meet evolving healthcare needs. Strategic partnerships and collaborations with research institutions and other pharmaceutical firms foster knowledge exchange and enhance innovation capacity. Additionally, the company also focuses on geographic expansion, entering new markets while customizing its marketing strategies to fit regional healthcare demands. By doing so, the company aims to enhance brand presence and customer loyalty. Sustainability is another key aspect of the company's strategy, as it seeks to comply with environmental regulations and advocate for responsible sourcing, thereby improving supply chain practices and contributing to community health.

Products and Services

The company boasts a diverse portfolio of products that cater to various therapeutic needs. The company's product range includes prescription medications addressing areas such as cardiology, gynecology, dermatology, and general health. These pharmaceuticals are developed through rigorous research and development practices that emphasize quality and efficacy. Additionally, the OTC product line includes pain relief medications, cough and cold remedies, and digestive aids, designed for easy access and convenience. Beyond conventional pharmaceuticals, the company invests in specialized formulations and biologics, underscoring its commitment to innovation and patient-centric solutions. This extensive product offering positions the company as a comprehensive provider of healthcare solutions.

The company provides a range of services aimed at enhancing healthcare delivery. These services include medical consultations and product education initiatives targeted at healthcare professionals and consumers alike. By offering these educational resources, the company fosters informed decision-making regarding health management. The commitment to quality is further supported by strict adherence to manufacturing standards and regulatory requirements, ensuring that all products delivered to consumers meet the highest safety and effectiveness benchmarks. Through these services, the company reinforces its role as a key player in the healthcare sector.

Geographical Markets Served

The company serves a broad geographical market, extending its reach across India and internationally. The company focuses on emerging markets where healthcare access is a priority, as well as established markets where innovation and specialized products can drive growth. Strategies implementing localized approaches aid in addressing the specific healthcare demands of diverse regions, ensuring that the company meets the unique needs of its global customer base.

Seasonality

The company experiences certain seasonality in its business operations, primarily influenced by consumer purchasing patterns and healthcare demands. Specific therapeutic areas may witness fluctuations in demand based on seasonal health conditions, such as increased respiratory illnesses during colder months. Additionally, variations in demand can occur due to trends in healthcare policies and regulatory changes, impacting the overall market dynamics.

Customers

The company serves a wide array of customers, including hospitals, pharmacies, healthcare providers, and consumers across multiple therapeutic areas. The customer base comprises both institutional clients, such as large healthcare systems, and individual consumers seeking OTC products. Additionally, the company focuses on building lasting relationships with its customers through high-quality products and responsive service, thereby enhancing customer loyalty and satisfaction.

Sales and Marketing Channels

The company employs diverse sales and marketing strategies that encompass various distribution channels. The company utilizes both direct and indirect channels to reach its target consumers, ensuring that its products are accessible in pharmacies, hospitals, and healthcare institutions. Digital marketing strategies play an increasingly important role in enhancing brand visibility and fostering engagement with healthcare professionals and consumers. The effective use of social media and healthcare forums strengthens the company’s outreach efforts. Additionally, the company engages in strategic partnerships with distributors and wholesalers, ensuring efficient supply chains and product availability.

History

J. B. Chemicals & Pharmaceuticals Limited was founded in 1976. The company was incorporated in 1976.

J. B. Chemicals & Pharmaceuticals Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Sales:** 70% **OTC Products:** 20% **Veterinary Products:** 10% **TOP 3 Markets:** **India:** 45% **USA:** 25% **Russia:** 15% J. B. Chemicals & Pharmaceuticals Limited generates the majority of its sales from the pharmaceutical industry, with prescription drugs...

At which locations are the company’s products manufactured?

**Production Sites:** 1. **India** - Main production facilities 2. **Daman** - Specialized production plant 3. **Ankleshwar** - Production site for pharmaceutical active ingredients J. B. Chemicals & Pharmaceuticals Limited produces the majority of its products in India. The main production fa...

What strategy does J. B. Chemicals & Pharmaceuticals pursue for future growth?

**Revenue Growth:** 18% (estimated for 2026) **Research and Development Investments:** 10% of revenue (2026) J. B. Chemicals & Pharmaceuticals Limited pursues a growth strategy that heavily relies on innovation and expansion into new markets. The company invests significantly in research an...

Which raw materials are imported and from which countries?

**Imported Raw Materials:** Active pharmaceutical ingredients (APIs), excipients, packaging materials **Countries of Origin:** China, Germany, USA, India (local procurement) J. B. Chemicals & Pharmaceuticals Limited primarily imports active pharmaceutical ingredients (APIs) and excipients that...

How strong is the company’s competitive advantage?

**Market share in India:** 3.5% (2025) **R&D expenses:** 8% of revenue (2025) **EBITDA margin:** 25% (2025) J. B. Chemicals & Pharmaceuticals Limited has a significant competitive advantage that manifests in several areas. The company holds a solid market share of 3.5% in the Indian pharmac...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** Estimated at around 30-35% (2026) **Insider Buys/Sells:** No significant transactions in the last year (2026) The institutional investor share in J. B. Chemicals & Pharmaceuticals Limited is estimated to be between 30 and 35 percent. This demonstrates institut...

What percentage market share does J. B. Chemicals & Pharmaceuticals have?

**Market share of J. B. Chemicals & Pharmaceuticals Limited:** 3.5% (estimated, 2026) **Top competitors and their market shares:** 1. **Sun Pharmaceutical Industries Ltd.:** 8.2% 2. **Dr. Reddy's Laboratories:** 7.5% 3. **Cipla Limited:** 6.9% 4. **Lupin Limited:** 6.3% 5. **Aurobindo Phar...

Is J. B. Chemicals & Pharmaceuticals stock currently a good investment?

**Revenue Growth:** 10% (estimated for 2026) **Profit Growth:** 8% (estimated for 2026) **R&D Expenses:** 7% of revenue (2025) J. B. Chemicals & Pharmaceuticals Limited has shown solid revenue growth of around 10% in recent years, attributed to a strong product pipeline and successful...

Does J. B. Chemicals & Pharmaceuticals pay a dividend – and how reliable is the payout?

**Dividend Yield:** 1.8% (estimated for 2026) J. B. Chemicals & Pharmaceuticals Limited has regularly distributed dividends to its shareholders in recent years. The dividend yield is currently around 1.8%, which can be considered moderate compared to other companies in the industry. The compan...

New support ticket

Explore

J. B. Chemicals & Pharmaceuticals Stock Value

J. B. Chemicals & Pharmaceuticals Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does J. B. Chemicals & Pharmaceuticals do?

J. B. Chemicals & Pharmaceuticals Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

J. B. Chemicals & Pharmaceuticals Stock Value

J. B. Chemicals & Pharmaceuticals Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does J. B. Chemicals & Pharmaceuticals do?

J. B. Chemicals & Pharmaceuticals Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.